parkinson, Parkinson's research notebook

Six readers

reader	found	score
genetics Open Targets	no genetic evidence; overall 0.00 from other evidence	0.00
cell type Human Protein Atlas	cell type enhanced, including microglia; strongest in neutrophils	0.75
chemistry Open Targets	reachable by antibody	0.45
trials ClinicalTrials.gov	no Parkinson's trials on record: an open field	1.00
literature PubMed	no papers tie it to Parkinson's yet	1.00
pathways Reactome	3 pathways; mostly other	0.30

No case: the score is under the bar. Receipt 16400

receipt 16408: GMIP in dopamine neurons, braak

power: full sample -0.40 (p 0.103, n 18), 95% CI -0.73 to +0.09. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: -0.41 (p 0.093, n 18). does not hold up.
composition: dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.49 (p 0.038, n 18). not the mix.
skeptic: leave-one-out range -0.55 to -0.32, sign flips 0; without severely affected donors -0.40 (p 0.103, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for GMIP in dopamine neurons.

case closed: nothing better to follow up.

receipt 16407: GMIP in microglia, braak

power: full sample +0.11 (p 0.652, n 18), 95% CI -0.37 to +0.55. the interval is wide: not enough donors to tell.
confounder: adjusted for sex: +0.07 (p 0.787, n 18). does not hold up.
composition: microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: +0.08 (p 0.754, n 18). could be the mix.
skeptic: leave-one-out range -0.00 to +0.25, sign flips 1; without severely affected donors +0.11 (p 0.652, n 18). fragile.
cell type: no other cell group does better.
axis: no measure beats "tracks Braak Lewy-body stage" for GMIP in microglia.

case closed: nothing better to follow up.

loading the receipts